This week, Dan introduces a brand-new guest to Stansberry Investor Hour... But he's no stranger to Stansberry Research.
Dave Lashmet, colleague and editor of Stansberry Venture Technology, joins Dan for a fast-paced talk on innovation, technology, and, of course, investing. His Venture Technology service uses a "venture capitalist" investing approach and focuses on biotechnology firms. And according to Dan, Dave is "well known as a man who scours the Earth for great ideas," thanks to his boots-on-the-ground research and networking at countless conferences and meetings.
The two dive into Stansberry Research's history – including how founder Porter Stansberry actually hired Dave after meeting him in college... where Dave was Porter's professor. And Dave also regales Dan with tales of his former job as a self-described "mix between an engineer and a businessperson inside a tech company."
Dan also commends Dave for his recent recommendation to Venture Technology subscribers to sell their remaining stake in Nvidia (NVDA) for an eye-popping 1,400% return. And Dave gives an in-depth analysis of the biggest risks to the company, ranging from overseas geopolitical tensions to direct competitors like Intel (INTC).
He also offers insights on the dichotomy between venture capitalists and "angel investors" and reveals exactly what he looks for in a company. Finally, he shares what investors should watch out for when researching prospective portfolio candidates.
Dave Lashmet
Editor of Stansberry Venture Technology
Dave Lashmet undertakes an intensive research process to discover under-the-radar technology, biotechnology, and medical companies poised for near-term growth. He was one of the first employees at Stansberry Research and is the editor of Stansberry Venture Technology. His unique insight into new technologies is responsible for some of the biggest gains in the history of the firm. Dave has spent 10 years teaching and writing about medicine and technology at major research universities, and he has done follow-up research at some of the most important facilities in North America, like Harvard Medical School, Johns Hopkins, MIT, and the Centers for Disease Control.
Subscribe for FREE. Get the Stansberry Investor Hour podcast delievered straight to your inbox.